KIAA0649 Inhibitors

KIAA0649 inhibitors, as represented in this context, mainly target RNA synthesis, processing, and metabolism, indirectly affecting RNA-binding protein functions like those associated with KIAA0649. For instance, compounds such as Actinomycin D and α-amanitin are well-known inhibitors of RNA synthesis. Actinomycin D binds DNA and hampers RNA synthesis, while α-amanitin specifically inhibits RNA polymerase II.

Furthermore, some inhibitors focus on specific stages of RNA processing. Pladienolide B and Spliceostatin A are compounds that target the SF3b complex, which plays a critical role in pre-mRNA splicing. By modifying splicing dynamics, these compounds can indirectly affect the functionality and interactions of RNA-binding proteins. Additionally, compounds like Ribavirin, a guanosine analog, and Cordycepin, an adenosine analog, integrate into RNA structures, affecting RNA metabolism and processing, subsequently influencing the activity of RNA-binding proteins.